Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing
- 1 January 2021
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 203 (1), 102-110
- https://doi.org/10.1164/rccm.202002-0321oc
Abstract
Rationale: Obstructive sleep apnea is recurrent upper airway obstruction caused by a loss of upper airway muscle tone during sleep. The main goal of our study was to determine if designer receptors exclusively activated by designer drugs (DREADD) could be used to activate the genioglossus muscle as a potential novel treatment strategy for sleep apnea. We have previously shown that the prototypical DREADD ligand clozapine-N-oxide increased pharyngeal diameter in mice expressing DREADD in the hypoglossal nucleus. However, the need for direct brainstem viral injections and clozapine-N-oxide toxicity diminished translational potential of this approach, and breathing during sleep was not examined. Objectives: Here, we took advantage of our model of sleep-disordered breathing in diet-induced obese mice, retrograde properties of the adeno-associated virus serotype 9 (AAV9) viral vector, and the novel DREADD ligand J60. Methods: We administered AAV9-hSyn-hM3(Gq)-mCherry or control AAV9 into the genioglossus muscle of diet-induced obese mice and examined the effect of J60 on genioglossus activity, pharyngeal patency, and breathing during sleep. Measurements and Main Results: Compared with control, J60 increased genioglossus tonic activity by greater than sixfold and tongue uptake of 2-deoxy-2-[F-18]fluoro-D-glucose by 1.5-fold. J60 increased pharyngeal patency and relieved upper airway obstruction during non-REM sleep. Conclusions: We conclude that following intralingual administration of AAV9-DREADD, J60 can activate the genioglossus muscle and improve pharyngeal patency and breathing during sleep.Keywords
This publication has 58 references indexed in Scilit:
- Effects of leptin and obesity on the upper airway functionJournal of Applied Physiology, 2012
- Genioglossus activity available via non-arousal mechanisms vs. that required for opening the airway in obstructive apnea patientsJournal of Applied Physiology, 2012
- Effect of age and weight on upper airway function in a mouse modelJournal of Applied Physiology, 2011
- Pathophysiology of Sleep ApneaPhysiological Reviews, 2010
- Differential Effects of Isoflurane and Propofol on Upper Airway Dilator Muscle Activity and BreathingAnesthesiology, 2008
- Effect of coactivation of tongue protrusor and retractor muscles on pharyngeal lumen and airflow in sleep apnea patientsJournal of Applied Physiology, 2007
- Genioglossus reflex inhibition to upper‐airway negative‐pressure stimuli during wakefulness and sleep in healthy malesJournal Of Physiology-London, 2007
- Effect of co‐activation of tongue protrudor and retractor muscles on tongue movements and pharyngeal airflow mechanics in the ratJournal Of Physiology-London, 1999
- Co‐activation of tongue protrudor and retractor muscles during chemoreceptor stimulation in the ratJournal Of Physiology-London, 1998
- Differential innervation of protruder and retractor muscles of the tongue in ratJournal of Comparative Neurology, 1995